These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 15794936
1. Hydrogen peroxide degradation and selective carbidopa-induced cytotoxicity against human tumor lines. Gilbert JA, Frederick LM, Pobst LJ, Ames MM. Biochem Pharmacol; 2005 Apr 15; 69(8):1159-66. PubMed ID: 15794936 [Abstract] [Full Text] [Related]
3. Cyclooxygenase-2 expression influences the growth of human large and small cell lung carcinoma lines in athymic mice: impact of an organoselenium compound on growth regulation. El-Bayoumy K, Rose DP, Papanikolaou N, Leszczynska J, Swamy MV, Rao CV. Int J Oncol; 2002 Mar 15; 20(3):557-61. PubMed ID: 11836568 [Abstract] [Full Text] [Related]
5. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Jensen SM, Gazdar AF, Cuttitta F, Russell EK, Linnoila RI. Cancer Res; 1990 Sep 15; 50(18):6068-74. PubMed ID: 2168288 [Abstract] [Full Text] [Related]
6. Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate. Curt GA, Jolivet J, Carney DN, Bailey BD, Drake JC, Clendeninn NJ, Chabner BA. J Clin Invest; 1985 Oct 15; 76(4):1323-9. PubMed ID: 2414316 [Abstract] [Full Text] [Related]
7. Paclitaxel cytotoxicity against human lung cancer cell lines increases with prolonged exposure durations. Georgiadis MS, Russell EK, Gazdar AF, Johnson BE. Clin Cancer Res; 1997 Mar 15; 3(3):449-54. PubMed ID: 9815704 [Abstract] [Full Text] [Related]
10. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer. Dosaka-Akita H, Akie K, Hiroumi H, Kinoshita I, Kawakami Y, Murakami A. Cancer Res; 1995 Apr 01; 55(7):1559-64. PubMed ID: 7882365 [Abstract] [Full Text] [Related]
11. Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up. de Vries EG, Meijer C, Timmer-Bosscha H, Berendsen HH, de Leij L, Scheper RJ, Mulder NH. Cancer Res; 1989 Aug 01; 49(15):4175-8. PubMed ID: 2545337 [Abstract] [Full Text] [Related]
13. Contaminants of PC-SPES are not responsible for cytotoxicity in human small-cell lung carcinoma cells. Sadava D, Winesburg J. Cancer Lett; 2005 Apr 08; 220(2):171-5. PubMed ID: 15766592 [Abstract] [Full Text] [Related]
18. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Zijlstra JG, de Vries EG, Mulder NH. Cancer Res; 1987 Apr 01; 47(7):1780-4. PubMed ID: 3028613 [Abstract] [Full Text] [Related]
19. Metabolic activation and cytotoxicity of 4-ipomeanol in human non-small cell lung cancer lines. Falzon M, McMahon JB, Schuller HM, Boyd MR. Cancer Res; 1986 Jul 01; 46(7):3484-9. PubMed ID: 3011249 [Abstract] [Full Text] [Related]
20. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells. Stordal BK, Davey MW, Davey RA. Cancer Chemother Pharmacol; 2006 Aug 01; 58(2):256-65. PubMed ID: 16283310 [Abstract] [Full Text] [Related] Page: [Next] [New Search]